Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Hoos

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Nature Reviews. Drug Discovery|March 12, 2016
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generationsAxel Hoos
Oncoimmunology|June 28, 2012
The immuno-oncology framework: Enabling a new era of cancer therapyAxel Hoos, Cedrik Britten
Expert Review of Vaccines|August 9, 2003
Vaccination with heat shock protein-peptide complexes: from basic science to clinical applicationsAxel Hoos, Daniel L Levey
Oncoimmunology|December 25, 2012
Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoringAxel Hoos, Sylvia Janetzki, Cedrik M Britten
Nature Reviews. Drug Discovery|April 9, 2021
Industrializing engineered autologous T cells as medicines for solid tumoursCedrik M Britten, Aiman Shalabi, Axel Hoos
Nature Reviews. Drug Discovery|June 16, 2018
The promise and challenges of immune agonist antibody development in cancerPatrick A Mayes, Kenneth W Hance, Axel Hoos
Nature Reviews. Drug Discovery|August 1, 2015
Big opportunities for small molecules in immuno-oncologyJerry L Adams, James Smothers, Roopa Srinivasan, et al.
Nature Biotechnology|October 15, 2011
A methodological framework to enhance the clinical success of cancer immunotherapyAxel Hoos, Cedrik M Britten, Christoph Huber, et al.
Surgical Oncology Clinics of North America|April 5, 2002
Randomized clinical trials in pancreatic cancerAlexander Stojadinovic, Axel Hoos, Murray F Brennan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2015
CCR 20th Anniversary Commentary: Immune-Related Response Criteria--Capturing Clinical Activity in Immuno-OncologyAxel Hoos, Jedd D Wolchok, Rachel W Humphrey, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Nature Reviews. Drug Discovery|March 12, 2016
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generationsAxel Hoos
Oncoimmunology|June 28, 2012
The immuno-oncology framework: Enabling a new era of cancer therapyAxel Hoos, Cedrik Britten
Expert Review of Vaccines|August 9, 2003
Vaccination with heat shock protein-peptide complexes: from basic science to clinical applicationsAxel Hoos, Daniel L Levey
Oncoimmunology|December 25, 2012
Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoringAxel Hoos, Sylvia Janetzki, Cedrik M Britten
Nature Reviews. Drug Discovery|April 9, 2021
Industrializing engineered autologous T cells as medicines for solid tumoursCedrik M Britten, Aiman Shalabi, Axel Hoos
Nature Reviews. Drug Discovery|June 16, 2018
The promise and challenges of immune agonist antibody development in cancerPatrick A Mayes, Kenneth W Hance, Axel Hoos
Nature Reviews. Drug Discovery|August 1, 2015
Big opportunities for small molecules in immuno-oncologyJerry L Adams, James Smothers, Roopa Srinivasan, et al.
Nature Biotechnology|October 15, 2011
A methodological framework to enhance the clinical success of cancer immunotherapyAxel Hoos, Cedrik M Britten, Christoph Huber, et al.
Surgical Oncology Clinics of North America|April 5, 2002
Randomized clinical trials in pancreatic cancerAlexander Stojadinovic, Axel Hoos, Murray F Brennan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2015
CCR 20th Anniversary Commentary: Immune-Related Response Criteria--Capturing Clinical Activity in Immuno-OncologyAxel Hoos, Jedd D Wolchok, Rachel W Humphrey, et al.
Pageof 8